Clinical Trials Directory

Trials / Completed

CompletedNCT04231357

Greater Trochanteric Pain Syndrome: Efficacy of Ultrasound Guided Platelet-rich Plasma vs Needle Tenotomy.

Great Trochanteric Pain Syndrome: Parallel Group, Blind Randomised Clinical Trial to Assess the Efficacy and Safety of PRP Injection Versus Needle Tenotomy With Lidocaine

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Isabel Andia · Other Government
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Great trochanteric pain syndrome (GTPS) is a difficult problem to manage and results in significant patient morbidity. This study is a single-center, randomized double-blind controlled trial. Eighty patients will be allocated to have an ultrasound (US)-guided injection of pure platelet-rich plasma (PRP) or needle tenotomy. Outcome data will be collected before the intervention, and at 3, 6, and 12 months after intervention. Main outcome measure: percent of patients that experience a reduction of 25% in hip outcome score (HOS) (responders) at 6 months after the intervention. Secondary outcome measures include percent of responders at three and twelve months, and pain reduction (VAS) at 3, 6, and 12 months. Adverse reactions or events will be recorded.

Detailed description

Evaluation of gluteal tendon pathology, including superoposterior and lateral aspects of gluteus medius and gluteus minimus(changes in echotexture, partial tears, calcified deposits, thickness, and loss of fibrillar pattern were evaluated by ultrasound at baseline, six and 12 m post-treatment. Peritrochanteric pathology including tensor fascia lata, trochanteric bursa, and cortical irregularities were also recorded. To analyze the relationship between the possible predictor variables (including sociodemographic and clinical factors, and imaging biomarkers, such as tendon degeneration and abnormalities in the peritrochanteric space) and changes in pain (VAS score) and functionality (HOS score), multivariate analyses were performed using multiple linear regressions.

Conditions

Interventions

TypeNameDescription
DRUGplatelet rich plasmaplatelet rich plasma prepared from peripheral blood using single spin centrifugation

Timeline

Start date
2019-12-04
Primary completion
2023-01-27
Completion
2023-04-28
First posted
2020-01-18
Last updated
2024-05-31

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04231357. Inclusion in this directory is not an endorsement.